SOURCE: ThermaFreeze Products Corporation

September 22, 2006 13:27 ET

ThermaFreeze Products™ Corporation Reports Cold-Chain Management Solution in Shipment of Vaccine

THEODORE, AL -- (MARKET WIRE) -- September 22, 2006 -- ThermaFreeze Products Corporation (PINKSHEETS: TFZP) released today temperature control performance results in the international shipment of high-value veterinary vaccine by Diamond Animal Health, Inc.

Unable to secure satisfactory cold-chain control packaging from several major US-based perishable-shipping companies, Diamond Animal Health turned to ThermaFreeze Products, which developed the successful solution.

For the vaccine to remain viable, the temperature during shipment had to remain between 1 and 9 degrees Centigrade (33 and 48 Fahrenheit) for five days during transit between Iowa and Norway. Either freezing or exceeding 9 degrees C would render the vaccine ineffective. The vaccine was shipped with ThermaFreeze™ refrigerant and ThermaBarrier™ thermal protection in 20-liter containers, each valued at USD $100,000.

ThermaFreeze designed a custom package that provided rigid strength protection for the 45-pound payload and high-efficiency protection against ambient temperatures, ranging from Midwestern heat to frigid temperatures experienced at altitude during the polar route to Europe. The vaccine temperature was finitely maintained by the patented ThermaFreeze™ refrigerant and patented ThermaBarrier™ temperature control material.

After initial testing, Diamond Animal Health conducted a range of field tests and supply shipments to Europe resulting in zero failures.

President Joe Murray stated that, "This is one more example of how the Company's solution-based cold-chain management products change the standard in the shipment of expensive perishables."

About ThermaFreeze Products Corporation:

ThermaFreeze Products Corporation, with product, process and system patents, is a solutions-based company for shipment of perishables, including frozen and refrigerated fish, meat, confections and other food items, pharmaceutical prescriptions, cold and hot medical compresses and other consumer requirements. The company's products replace wet ice and gel packs for temperature control and enhance the effectiveness of dry ice.

Legal Notice Regarding Forward-Looking Statements

No statement herein should be considered an offer or a solicitation of an offer for the purchase or sale of any securities. This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although the Company believes that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, it can give no assurance that such expectations and assumptions will prove to have been correct. Forward-looking statements, which involve assumptions and describe our future plans, strategies, and expectations, are generally identifiable by use of the words "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to adverse economic conditions, intense competition, lack of meaningful research results, entry of new competitors and products, adverse federal, state and local government regulation, inadequate capital, unexpected costs and operating deficits, increases in general and administrative costs, termination of contracts or agreements, technological obsolescence of the Company's products, technical problems with the Company's research and products, price increases for supplies and components, litigation and administrative proceedings involving the Company, the possible acquisition of new businesses or technologies that result in operating losses or that do not perform as anticipated, unanticipated losses, the possible fluctuation and volatility of the Company's operating results, financial condition and stock price, losses incurred in litigating and settling cases, dilution in the Company's ownership of its business, adverse publicity and news coverage, inability to carry out research, development and commercialization plans, loss or retirement of key executives and research scientists, changes in interest rates, inflationary factors, and other specific risks. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect the events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Contact Information

  • Contact:
    ThermaFreeze Products Corporation
    Shareholder Communications
    Joseph Murray
    251-653-0000
    Email: thermobal@Yahoo.com